These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34143299)

  • 61. Somatic and renal effects of growth hormone in rats with chronic renal failure.
    Kawaguchi H; Hattori M; Ito K
    Pediatr Nephrol; 1997 Jun; 11(3):280-4. PubMed ID: 9203173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 63. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
    Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current and potential therapeutic uses of growth hormone and insulin-like growth factor I.
    Hintz RL
    Endocrinol Metab Clin North Am; 1996 Sep; 25(3):759-73. PubMed ID: 8879998
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential effects of short-term growth hormone therapy on the cardiovascular risk profile in patients with chronic kidney disease: a pilot study.
    Fischer DC; Nissel R; Puhlmann A; Mitzner A; Tiess M; Schmidt R; Haffner D
    Clin Nephrol; 2009 Nov; 72(5):344-52. PubMed ID: 19863876
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
    Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
    J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M; Hauri C; Zapf J
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly.
    Niculescu D; Purice M; Coculescu M
    Pituitary; 2013 Jun; 16(2):168-74. PubMed ID: 22562529
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study.
    Fredstorp L; Werner S
    J Endocrinol Invest; 1993 Apr; 16(4):253-8. PubMed ID: 8514980
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of rhGH and rhIGF-1 on renal growth and morphology.
    Mehls O; Irzynjec T; Ritz E; Eden S; Kovàcs G; Klaus G; Floege J; Mall G
    Kidney Int; 1993 Dec; 44(6):1251-8. PubMed ID: 7905540
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.
    Segev Y; Eshet R; Yakir O; Haim N; Phillip M; Landau D
    Diabetologia; 2007 Jun; 50(6):1327-34. PubMed ID: 17443310
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Growth hormone/insulin-like growth factor system in children with chronic renal failure.
    Tönshoff B; Kiepe D; Ciarmatori S
    Pediatr Nephrol; 2005 Mar; 20(3):279-89. PubMed ID: 15692833
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impaired phosphorylation of JAK2-STAT5b signaling in fibroblasts from uremic children.
    Ugarte F; Irarrazabal C; Oh J; Dettmar A; Ceballos ML; Rojo A; Ibacache MJ; Suazo C; Lozano M; Delgado I; Cavada G; Azocar M; Delucchi A; Cano F
    Pediatr Nephrol; 2016 Jun; 31(6):965-74. PubMed ID: 26747624
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG
    Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sensitivity to exogenous GH and reversibility of the reduced IGF-I gene expression in aging rats.
    Velasco B; Cacicedo L; Melian E; Fernández-Vázquez G; Sánchez-Franco F
    Eur J Endocrinol; 2001 Jul; 145(1):73-85. PubMed ID: 11415855
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Growth Hormone and Insulin-Like Growth Factor Dysregulation in Pediatric Chronic Kidney Disease.
    Brown DD; Dauber A
    Horm Res Paediatr; 2021; 94(3-4):105-114. PubMed ID: 34256372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.